Nasdaq Inc vs Twist Bioscience Corp — how do they compare? Nasdaq Inc trades at $90.25 (market cap $51.96B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Nasdaq Inc is far larger — about 9.5× Twist Bioscience Corp's market cap, and Nasdaq Inc pays a 1.22% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| NDAQ | TWST | |
|---|---|---|
Market Cap | $51.96B | $5.45B |
Sector | Financials | Health |
52-Week High | $100.98 | $102.88 |
52-Week Low | $76.85 | $24.16 |
Enterprise Value | $59.02B | $5.37B |
Dividend Yield | 1.22% | — |
Trailing returns across standard periods
Latest headlines on both assets
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →